Zhejiang CONBA Pharmaceutical Co Ltd
Zhejiang CONBA Pharmaceutical Co.,Ltd. engages in the research, development, production, and sales of pharmaceuticals and health products in mainland China. It offers medicines, Chinese patent medicines, chemical medicines, Chinese herbal medicine slices, and health products. The company also provides Chinese decoction pieces; over-the-counter medications; healthy consumer products, including nut… Read more
Zhejiang CONBA Pharmaceutical Co Ltd (600572) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.019x
Based on the latest financial reports, Zhejiang CONBA Pharmaceutical Co Ltd (600572) has a cash flow conversion efficiency ratio of 0.019x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥133.43 Million) by net assets (CN¥7.16 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang CONBA Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Zhejiang CONBA Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang CONBA Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang CONBA Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mineralys Therapeutics, Inc. Common Stock
NASDAQ:MLYS
|
-0.050x |
|
IperionX Limited American Depositary Share
NASDAQ:IPX
|
0.017x |
|
Tokuyama Corporation
F:TBT
|
N/A |
|
American Superconductor Corporation
NASDAQ:AMSC
|
0.006x |
|
HomeCo Daily Needs REIT
PINK:HDNRF
|
0.020x |
|
Acadian Asset Management Inc
NYSE:AAMI
|
-0.285x |
|
Bossard Holding AG
OTCGREY:BHAGF
|
0.027x |
|
Xenia Hotels & Resorts Inc
NYSE:XHR
|
0.052x |
Annual Cash Flow Conversion Efficiency for Zhejiang CONBA Pharmaceutical Co Ltd (2003–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang CONBA Pharmaceutical Co Ltd from 2003 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥6.91 Billion | CN¥1.01 Billion | 0.146x | +19.80% |
| 2023-12-31 | CN¥7.35 Billion | CN¥898.64 Million | 0.122x | -22.50% |
| 2022-12-31 | CN¥7.32 Billion | CN¥1.16 Billion | 0.158x | +31.05% |
| 2021-12-31 | CN¥7.39 Billion | CN¥889.94 Million | 0.120x | -48.47% |
| 2020-12-31 | CN¥5.35 Billion | CN¥1.25 Billion | 0.234x | +24.76% |
| 2019-12-31 | CN¥4.94 Billion | CN¥925.50 Million | 0.187x | +98.73% |
| 2018-12-31 | CN¥5.79 Billion | CN¥545.78 Million | 0.094x | -22.70% |
| 2017-12-31 | CN¥5.84 Billion | CN¥712.27 Million | 0.122x | -43.59% |
| 2016-12-31 | CN¥4.49 Billion | CN¥969.71 Million | 0.216x | +18.66% |
| 2015-12-31 | CN¥4.57 Billion | CN¥831.26 Million | 0.182x | -0.61% |
| 2014-12-31 | CN¥3.37 Billion | CN¥617.43 Million | 0.183x | +101.72% |
| 2013-12-31 | CN¥2.59 Billion | CN¥235.36 Million | 0.091x | -9.81% |
| 2012-12-31 | CN¥2.44 Billion | CN¥245.76 Million | 0.101x | -13.82% |
| 2011-12-31 | CN¥1.61 Billion | CN¥188.36 Million | 0.117x | +59.22% |
| 2010-12-31 | CN¥1.72 Billion | CN¥125.93 Million | 0.073x | -45.11% |
| 2009-12-31 | CN¥1.15 Billion | CN¥153.39 Million | 0.134x | +24.75% |
| 2008-12-31 | CN¥919.66 Million | CN¥98.56 Million | 0.107x | +14.52% |
| 2007-12-31 | CN¥854.74 Million | CN¥79.98 Million | 0.094x | -17.51% |
| 2006-12-31 | CN¥627.66 Million | CN¥71.20 Million | 0.113x | -42.62% |
| 2005-12-31 | CN¥595.08 Million | CN¥117.65 Million | 0.198x | +70.62% |
| 2004-12-31 | CN¥565.05 Million | CN¥65.47 Million | 0.116x | -58.37% |
| 2003-12-31 | CN¥239.44 Million | CN¥66.64 Million | 0.278x | -- |